Drug Shortage Report for DEPO-MEDROL

Last updated on 2026-03-04

Report ID 278305
Drug Identification Number 00030767
Brand name DEPO-MEDROL
Common or Proper name DEPO-MEDROL
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHYLPREDNISOLONE ACETATE
Strength(s) 80MG
Dosage form(s) SUSPENSION
Route of administration INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Packaging size 5 X 1ML
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2026-03-04
Estimated end date 2026-03-13
Actual end date
Shortage status Anticipated shortage
Updated date 2026-03-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2026-03-04 French Compare
v3 2026-03-04 English Compare
v2 2026-02-18 French Compare
v1 2026-02-18 English Compare

Showing 1 to 4 of 4